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CObjectives: EQ-5D is widely used in studies with adults as a source of ge-
neric health-related quality of life information and utility weights to inform
resource allocation decisions. This methodological systematic review de-
scribes the extent to which EQ-5D has been used in the evaluation of chil-
dren’s health care, assesses psychometric properties, and makes recom-
mendations for future good practice. Methods: Systematic searches of
atabases and the Internet to identify studies published during 2000–2010
hat either used EQ-5D with children younger than age 19 years as an
utcome measure or reported psychometric data. Study characteristics,
ncluding measures and psychometric data, were extracted into tables for
nalysis. Results: We identified 29 studies that used four versions of the
Q-5D: adult EQ-5D, EQ-5D-Y, Dutch EQ-5D child, and extended with cog-
itive dimension, EQ-5DC. Twelve of 29 studies did not specify the
Q-5D version used. Existing literature lacks detail on the specific use of
Q-5D and its potential effects on findings. Version use and psychometric O
m
t
cono
an St
al So
doi:10.1016/j.jval.2011.07.011roperties were inadequately reported. There are large gaps in current
nowledge of psychometric properties across all versions when used with
hildren. Conclusions: For reasons of comparability with resource use
cross adult and children’s services, there are arguments for continued
se of EQ-5D in studies with children. We recommend use of EQ-5D along-
ide children-specific quality of life measures and disease-specific mea-
ures. Researchers are encouraged to undertake methodological and phil-
sophical analyses to better understand and improve evidence as to how
dults who make decisions about resource allocation can best take ac-
ount of children in decision making.
eywords: adolescents, children, economic evaluation, EQ-5D, health-
elated quality of life, QALY.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Health-related quality of life (HR-QoL) describes the influence of physi-
cal and mental disorders and disability on the general well-being of a
person [1]. Assessment of HR-QoL is particularly important for compar-
ing outcomes of healthcare interventions and for supporting decisions
regarding the allocation of resources in healthcare. Assessing HR-QoL
involves both the description of health states and the elicitation of peo-
ple’s values of these health states. Generic HR-QoL instruments allow a
comparison of health outcomes between different disorders, different
groups of children, as well as between children and adults. EQ-5D, a
generic instrument for measuring HR-QoL, is widely used for economic
evaluation in many areas of health research [2]. It was recommended
for use in cost-effectiveness studies in the United States by the Wash-
ingtonPanelonCostEffectiveness inHealthandMedicine [3],andinthe
United Kingdom by the National Institute for Health and Clinical Excel-
lence (NICE) [4,5]. Although initially designed for adults, EQ-5D has been
used to assess the HR-QoL in children with orthopaedic problems [6],
arthritis [7], attention deficit/hyperactivity disorder [8,9], burns [10],
chistosomiasis [11], and other health conditions. A number of reviews
ublished in the past 10 years discuss the use of generic HR-QoL instru-
* Address correspondence to: R.T. Edwards, Centre for Health E
Behavioural Sciences, Bangor University, Dean Street Building, De
E-mail: r.t.edwards@bangor.ac.uk
1098-3015/$36.00 – see front matter Copyright © 2011, Internation
Published by Elsevier Inc.ents in children [12–16]. EQ-5D, however, was not included in any of
hese reviews, leading to a gap in current knowledge.
Review aim
The aim of this methodological review was to determine the ap-
propriateness of the EQ-5D for the evaluation of HR-QoL in chil-
dren and to inform the decision making process in allocating re-
sources to children’s health care. To focus the review, we
formulated the following questions:
1. What versions of the EQ-5D have been used in studies with children?
2. In what types of studies and contexts has the EQ-5D been used
with children?
3. What evidence exists concerning reliability and validity of the
EQ-5D when used with children?
Methods
We conducted a quantitative methodological review using sys-
tematic principles for searching, screening, and data extraction
and handling [17]. We used setting, perspective, intervention,
mics and Medicines Evaluation, IMSCaR, College of Health and
reet, Bangor, LL57 1UT, UK.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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1118 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 1 7 – 1 1 2 9comparison, evaluation (SPICE) to define the scope of the review
and evidence of interest (see Table 1). Searching, screening and
ata extraction was undertaken by NH, and checked by JN.
EQ-5D versions
We were interested in finding out about the use and validity of all
versions of the EQ-5D in studies with children, including the fol-
lowing versions, and any other versions identified via a compre-
hensive search.
Adult EQ-5D (now known as the EQ-5D-3 level)
The EQ-5D-L3 instrument [18] is based on a descriptive system that
efines health in five dimensions: mobility, self-care, usual activities,
ain/discomfort, and anxiety/depression. Each dimension has three
esponse categories: no problem, some problem, and severe prob-
em. The descriptive system defines a total of 243 (35) possible states
with two additional states (dead and unconscious). The question-
naire also includes a visual analog scale (VAS), sometimes called a
feeling thermometer, with zero representing worst imaginable
health and 100 representing best imaginable health. EQ-5D output
includes health profiles derived from the descriptive system, self-
rated health status derived from the VAS, and a weighted index de-
rived using preference weights for the 243 health states. These are
used to produce quality-adjusted life-years (QALYs). The EQ-5D-3L
preference (utility) weights were derived for the adult population us-
ing time trade-off and VAS methods [2]. It has been translated into
more than 150 languages [2] and national value sets have been de-
rived for 15 countries, including the United Kingdom [19]. EQ-5D is
widely used in the clinical and economic evaluation of health care
interventions in adults due to high reliability, responsiveness, good
validity and short completion time. The EQ-5D-3L version is gener-
ally considered suitable for children aged 12 years and odler [2]. The
adult questionnaire includes versions for self and proxy report. The
proxy version is presented using two scripts. The first script asks
the proxy to rate how he/she (the proxy) would rate a patient’s
HR-QoL. The second script asks the proxy to rate how he/she (the
proxy) thinks a patient would rate his/her own HR-QoL [2]. The
first proxy script is commonly accepted in studies with children.
EQ-5D-Y (youth)
The EuroQol child-friendly version EQ-5D-Y (youth) was recently de-
veloped from the adult EQ-5D and validated for measurement of HR-
QoL in children and adolescents aged 7 to 12 years [20,21]. The EQ-
5D-Y questionnaire has been translated into nine languages [2]. The
ain differences between the EQ-5D and the EQ-5D-Y are revisions
o domain definitions, introduction of age-appropriate wording and
daptations to layout. The purpose of the adaptation was to clarify
he meaning of dimensions for younger respondents and to establish
hat items referred exclusively to health-related impairment and not
o age-related difficulties. For example, “self-care” was modified to
looking after myself” and the usual activities domain listed going to
chool, hobbies, sports, playing, and doing things with family or
riends as the examples of activities. The additional inclusion of child
nd adolescent specific domains was not considered. Modified uni-
orm answers were also included as illustrated below.
EQ-5D EQ-5D-Y
Anxiety/depression Feeling worried, sad or
unhappy
I am not anxious or depressed I am not worried, sad or
unhappy
I am moderately anxious or
depressed
I am a bit worried, sad or
unhappy
I am extremely anxious or I am very worried, sad or
depressed unhappy T S M
1119V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 1 7 – 1 1 2 9Because the EQ-5D was originally developed for use with
adults, concerns remain about the EQ-5D-Y adaptation and its
appropriateness in studies with children. Issues such as age suit-
ability, coverage of a broader range of day-to-day functioning, and
the lack of children-specific utility weights significantly limit its
application in economic evaluations of health care programs.
EQ-5D 5 level
More recent developments include the launch of a new EQ-5D-5L
(EQ-5D 5 level) version in 2009, which aims to improve sensitivity
and reduce ceiling effects of the existing EQ-5D-3L version. This is
now available in paper format in more than 40 languages. The
EQ-5D-5L still consists of questions and a VAS. The descriptive
system comprises the same five dimensions as the EQ-5D-3L. Each
dimension, however now has five levels: no problems, slight prob-
lems, moderate problems, severe problems, and extreme prob-
lems. The respondent is asked to indicate his/her health state by
ticking (or placing a cross) in the box against the most appropriate
statement in each of the five dimensions. This decision results in a
one-digit number expressing the level selected for that dimension.
The digits for five dimensions are combined in a five-digit number
describing the respondent’s health state [2].
EQ-5D bolt-ons/dimension extensions
According to the EuroQol Web site [2], another new addition is
Fig. 1 – Flow diagram of lbolt-ons (add-ons/dimension extensions) that identify key dimen-sions of HRQol that may be important to patients but are not cap-
tured by the EQ-5D.
Search strategy
Database searches were conducted for the period between 1999
and 2010 to identify peer-reviewed publications on the use of
EQ-5D in studies with children. This time span was chosen as most
experience of using the EQ-5D with child populations has occurred
during the past 10 years. The EuroQol database was searched first
for all studies including children. We then searched the following
electronic databases: Medline, Caredata, CAB direct, CINAHL, Co-
chrane Library, Emerald, PsycINFO, and BIOSIS Previews. The full
text of articles was searched for the terms “EQ-5D,” “children,”
“adolescents,” “infants,” and “quality of life.” In addition, a broad
search across all disciplines and sources was performed using
Google Scholar advanced option, including “all the words” and
“everywhere in the article” for the above terms. Reference lists of
relevant studies were also searched.
Inclusion criteria
To be included papers had to satisfy the following criteria: full-
length reports, report of original EQ-5D data, reports of EQ-5D data
used in economic models, published in peer-reviewed journals,
published in English, and report data for children and young peo-
ture through the review.iteraple younger than age 19 years.
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Items including abstracts, conference proceedings, review arti-
cles, and research articles in languages other than English were
excluded from the review.
Critical appraisal
We conducted a methodological review of the use and reliability
and validity of the EQ-5D and did not appraise the quality of in-
cluded studies. All studies that met the inclusion criteria were
examined. The psychometric properties of different EQ-5D ver-
sions were assessed in terms of feasibility, validity, reliability, and
sensitivity [22,23]. Validity reflects whether the instrument really
easures HR-QoL and includes different types of validity such as
ontent validity, criterion validity, and construct validity (conver-
ent and discriminant). Content validity determines if all impor-
ant aspects of the construct are covered. Criterion validity con-
iders if scores on the questionnaire agree with gold standard
easures. Construct validity reflects the degree to which one
easure is similar (convergent validity) or different (discriminant
alidity) from another measure. Reliability reflects the temporal
tability of an instrument, such as test–retest correlation. Sensi-
ivity describes the ability of instrument to detect changes in
ealth status. If more than 20% of responses produce maximum or
inimum scores, this indicates ceiling or floor effects, respec-
ively. Feasibility is determined by measuring completion rates of
n instrument. Concordance measures agreement/disagreement
etween assessments provided by different responders (e.g., self
nd proxy assessment).
Data abstraction and synthesis
Study characteristics (e.g., population, setting, intervention, com-
parisons, type and use of EQ-5D, and other measures) and psycho-
metric data addressing relevant quality criteria were extracted
into purposefully developed extraction tables for comparison and
analysis (Tables 2 and 3).
Results
Search outcome
Figure 1 summarizes the flow of literature through the review. The
search strategy was highly specific. The EuroQol database con-
tained 29 relevant studies. A wider key word search of relevant
databases identified 48 publications. Duplicates and studies not
meeting the inclusion criteria were excluded. A secondary search
of Google Scholar did not reveal any additional studies beyond
those found on the EuroQol Web site [2]. Twenty-nine studies were
included in the review.
EQ-5D versions
We identified four versions of the EQ-5D questionnaire that were
used in 29 included studies with children: the EQ-5D adult version,
child-friendly version EQ-5D-Y, the Dutch EQ-5D child version,
and an extended questionnaire with a cognitive dimension EQ-
5DC. The search identified at least three proxy versions, corre-
sponding to the adult EQ-5D, child-friendly EQ-5D-Y, and Dutch
child EQ-5D questionnaires. Twelve out of 29 included studies did
not specify which EQ-5D version was used (Table 2). No study
reported using the EQ-5D-5L.
We found that the adult self-report version (EQ-5D-3L) was
used in children aged 10 to 15 years and older, whereas for younger
children the proxy version was completed by their parents or care-
givers [9,24–27]. The EQ-5D-Y questionnaire has been validated in
five countries, including Germany, Italy, South Africa, Spain, and
Sweden [20,21]. It was tested in a cohort of children with cystic pfibrosis starting from age 9 years [28], and in a study of children
with eczema from age 7 years upward [29], and in general popula-
tions [30,31]. The Dutch EQ-5D children version was administered
in studies by Willems et al. [26,27] and contains some alterations
in phrasing. It has been used for self-assessment of HR-QoL in
children aged 12 years and older, and for proxy assessment in
children younger than age 12 years. An English translation of this
version is presented elsewhere [26]. The EQ-5D version extended
with cognitive dimension (EQ-5DC) was used in a study of chil-
dren with schistosomiasis [11]. In addition to the existing five do-
mains, the questionnaire included the domain Cognition with
three response categories: no problem, some problem, and severe
problem [32]. Attributes associated with cognition included mem-
ory, concentration, coherence, and intelligence quotient.
Study types and contexts
Among the 29 included studies were six cross-sectional studies, 16
cohort studies, three randomized controlled trials, two modelling
studies, and two studies on valuation health states (Table 2). Sam-
ple sizes varied from six to 2809 children/adolescents aged 1 to 18
years. Thirteen articles investigated HR-QoL in children with a
range of health conditions. Seven studies used the EQ-5D for eco-
nomic evaluation of health care programs. Six studies compared
the performance of EQ-5D with other generic instruments: Health
Utility Index (HUI) marks 2 and 3, Quality of Life Questionnaire for
Children (TACQOL), Pediatric Quality of Life Inventory, Cantril-
ladder (life satisfaction ladder), Strengths and Difficulties Ques-
tionnaire; Child Health and Illness Profile - Child Edition, Child
Health Questionnaire-Parent Form; KIDSCREEN (a health-related
quality of life instrument for children and adolescents), and the
Short Form-36 health survey questionnaire [6,8,20,26,28,36].
Cross-sectional studies evaluated performance of the EQ-5D-Y
in children from the general population in Germany, Italy, South
Africa, Spain, and Sweden [20,21,35,37]. Cohort studies investi-
gated HR-QoL in children with different disorders, including or-
thopaedic problems [6], arthritis [7], attention deficit/hyperactivity
isorder [8,9], burns [10], schistosomiasis [11], and other health
onditions [38,39]. In randomized controlled trials EQ-5D was used
s an outcome measure of health care interventions, such as hy-
rotherapy in children with juvenile idiopathic arthritis [7], telem-
nitoring of expiratory flow measurements in children with
sthma [27], prophylaxis of bleedings in hemophilia patients [40],
nd using water softeners in children with eczema [29]. Two arti-
les present Markov health state transition models that used
Q-5D data to predict costs and effects of mass vaccination of
hildren against rotavirus infection in the Netherlands [41] and to
ssess the cost-effectiveness of infliximab treatment in children
ith Crohn’s disease [42]. Health state valuation studies were con-
ucted to estimate EQ-5D utility scores for children using health
tate descriptions for a hypothetical child with the specified per-
anent sequelae after meningitis [36] and acute rotavirus gastro-
nteritis [43]. Economic evaluations including cost-effectiveness,
ost-utility, and cost-of-illness analysis, were conducted as a sep-
rate investigation [44,45], or alongside randomized controlled tri-
ls [7,27,29,40].
Reliability and validity of different EQ-5D versions in
children
Twenty studies reported some psychometric data, but big gaps in
knowledge remain for all four versions (see Tables 2 and 3).
mongst the four versions, EQ-5D-Y had higher feasibility in most
ut not all studies, and it was used for self-assessment in younger
hildren (starting from age 8 years). Where a direct comparison
as made—children and young people aged 8 to 18 years found
he EQ-5D-Y easier to complete than the adult EQ-5D, but more
roblems were reported on the child version compared with the
Table 2 – Summary of literature on EQ-5D use in studies with children.
Reference Sample characteristics Health condition Type of study Mode of assessment Reliability and validity
EQ-5D-Y
Boyle et al. 2010 [30] Sample number: 1771
Mean age: 13.2 y
Country: UK
General population Cross-sectional Self-assessment There is weak correlation between physical activity, Body
Mass Index and EQ-5D. EQ-5D and PedsQol unable to
discriminate between more active and less active
children.
Burström et al. 2010 [37] Sample number: 490
Age range: 8-12 y
Country: Sweden
General population Cross-sectional Self-assessment Feasibility: 100%;
Discriminant validity – children with disabilities had
significantly more problems with ‘mobility’ and ‘pain or
discomfort’ (P  0.05); children who had consulted
healthcare on the dimension of ‘mobility’ and ‘doing
usual activities’ had significantly more problems (P 
0.01); for children with overweight or obesity in the
dimension ‘feeling worried or sad’ (P  0.01); VAS was
significantly lower for children with two or more
clinical characteristics (P  0.01).
Ravens-Sieberer et al.
2010 [20]
Sample number: 2809
Age range: 8–18 y
Countries: Germany, Italy,
South Africa, Spain, Sweden
General population Cross-sectional Self-assessment Feasibility: 91%–100%;
Test-retest reliability: 69.8%–99.7%;
Convergent validity compared to KIDSCREEN:
r  0.52–0.55 (different domains);
Convergent validity compared to Cantril-ladder:
r  0.37–0.1 (different domains);
Ceiling effect: up to 99%.
ICC for VAS 0.82–0.83
Kappa coefficients up to 0.67
Wu et al. 2010 [31] Sample number: 3421
Age range: 10–11 y
Country: Canada
General population Cross-sectional Self-assessment Feasibility very few children were not able to answer the
questions. Ceiling effect 37.8%
Eidt-Koch et al. 2009
[28]
Sample number: 96
Age range: 8–17
Country: Germany
Cystic fibrosis Cohort study Self-assessment Convergent validity compared to CFQ:
r  0.625–0.279 (different domains)
EQ-5D-Y and EQ-5D adult
Wille et al. 2010 [21] Sample number: 2809
Age range: 8–18 y
Countries: Germany, Italy,
South Africa, Spain, Sweden
General population Cross-sectional Self-assessment Feasibility: 97.7%–99.7% for EQ-5D-Y; 91.5%–99.7% for EQ-
5D adult version.
Children found EQ-5D-Y easier to fill in than adult
version.
Children reported more problems on EQ-5D-Y ‘mobility
(walking about) (P  0.05 in Germany and South Africa);
‘Having pain or discomfort’ (P  0.05 in Germany and
Spain), and ‘Feeling worried, sad or unhappy’ domains
than in the EQ-5D (P  0.05 between the EQ-5D and EQ-
5D-Y in all three countries).
Jelsma 2010 [35] Sample number: 521
Age range: 14–18 y
Country: South Africa
General population Cross-sectional Self-assessment Feasibility: 98% for EQ-5D-Y;
92%–93% for EQ-5D adult version. EQ-5DY has significantly
smaller number of missing responses than adult EQ-5D. A
larger number of children reported some problems with
mobility, self-care and pain-discomfort in the EQ-5D-Y
version compared with EQ-5D.
(continued on next page)
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Table 2 (continued)
Reference Sample characteristics Health condition Type of study Mode of assessment Reliability and validity
Child Dutch
Willems et al. 2009 [26] Sample number: 343
Age range: 7–18 y
Country: Netherlands
Asthma, rheumatic disorders,
diabetes, speech, language
and hearing disorders
Cohort study Self-assessment for
12 y and older,
proxy-assessment
for  12 y
Test–retest reliability: ICC  0.25 to 1.00
Convergent validity compared to TACQOL varied across
domains:
r  0.57 (Highest correlation EQ-5D utility and TACQOL
Autonomy, and Mobility 0.48) to –0.15.
VAS competed by 91% parents
7 of 36 children with a hearing or language disorder
missed scores.
EQ-5D discriminated most in children with a rheumatic
disorder.
Willems et al. 2007 [27] Sample number: 56
Mean age: 10.85 y
Country: Netherlands
Asthma Randomised
controlled
trial
Self-assessment for
12 y and older,
proxy-assessment
for  12 y
NR
Stolk et al. 2000 [24] Sample number: 232
Age range: 1–51 y (number
of children is not specified)
Country: Australia
Imperforate anus Cohort study Self-assessment for
15 years (EQ-5D)
and 12 (EQ-5D-
VAS), proxy-
assessment for 1–15
years (EQ-5D) and
1–12 (EQ-5D-VAS)
Feasibility: 100%
Convergent validity compared to TACQOL
r  0.712 to –0.227 for different domains.
Construct validity: mean correlation between
contextually similar domains with TACQOL 0.55
EQ-5DC
Jia et al. 2007 [11] Sample number: 31
Age range: 5–14 y
Country: China
Chronic schistosomiasis Cohort study NR NR
Polinder et al. 2005 [25] Sample number: 1221
Age range: 5–14 y
Country: Netherlands
Childhood injury Cohort study Self-assessment for 13–
14 y proxy-
assessment for 13 y
Feasibility: 87%
Relatively high score of head injuries partly reflects that the
EQ-5D insufficiently discriminates between injuries with
and without cognitive sequelae.
EQ-5D adult
Matza et al. 2005 [8] Sample number: 126
Mean age: 11.8 y
Countries: US and UK
Attention-deficit hyperactivity
disorder
Cohort study Proxy-assessment by
parents
Feasibility: 99%;
Convergent validity: EQ-5D (index score) compared to
CHQ-PF50 (different domains): r  0.30 to 0.64; EQ-5D
(index score) compared to CHIP-CE (different domains):
r  0.24 to 0.51.
Secnik et al. 2005 [9] Sample number: 83
Mean age: 12.6 y
Country: UK
Attention-deficit hyperactivity
disorder
Cohort study Proxy-assessment by
parents
Standard gamble raw score for child’s current health state
moderately correlated with EQ-5D VAS (r  0.26). The
correlation for the EQ-5D index score was positive but
weak. Correlation between EQ-5D and standard gamble
adjusted score were small.
Vitale et al. 2001 [6] Sample number: 196
Age range: 10–18 y
Country: USA
Orthopaedic problems Cohort study Self-assessment Feasibility:  98%;
Convergent validity: EQ-5D (index score) compared to SF-
36 (different domains) r  0.29 to 0.71;
Criterion validity: EQ-5D (index score) compared to
clinicians’ score r  0.33;
Ceiling effect: 50%.
Construct validity: EQ-5D aligned more closely to SF-36
physical health factor.
(continued on next page)
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Table 2 (continued)
Reference Sample characteristics Health condition Type of study Mode of assessment Reliability and validity
Klaassen et al. 2010 [33] Sample number: 49
Age range: 8–18 y
Country: Canada
Hodgkin disease Cohort study Self-assessment Responsiveness: effect size  1.33.
Construct validity: EQ-5D correlated strongly with 5 other
measures at time 1 (0.52–0.65)
Klaassen et al. 2010 [34] Sample number: 49
Age range: 8–18 y
Country: Canada
Hodgkin disease Cohort study Self-assessment and
proxy-assessment by
parents and nurses
Concordance: child/parent ICC  0.39–0.87; child/nurse
ICC  0.40–0.87.
EQ-5D version used not reported
Punekar et al. 2010 [42] Sample: hypothetical cohort
Age range: 6–17 y
Country: UK
Crohn’s disease Modelling
study
EQ-5D data was taken
from adult Crohn’s
disease study
NR
Hanberger et al. 2009
[38]
Sample number: 400
Mean age: 13.2 y
Country: Sweden
Type 1 diabetes Cohort study NR Higher EQ-5D correlated with a lower degree of disease
severity in adolescents (r  0.41, P  0.001) and their
parents (r  0.46, P  0.001). Higher EQ-5D also
correlated with a lower frequency of problems with
diabetes in adolescents (r 0.24, P  0.003) and their
parents (r  36, P  0.001).
Goossens et al. 2008 [41] Sample: hypothetical cohort
Age range: 0–4 y
Country: Netherlands
Rotavirus Modelling
study
Standardised proxy-
assessment by
general practitioners
and paediatricians
NR
Hoots et al. 2008 [40] Sample number: 16
Age range: 5–17 y
Countries: Argentina, Brazil,
Bulgaria, Philippines,
Poland, Romania, Russia,
South Africa, Spain,
Turkey, US
Haemophilia Randomised
controlled
trial
NR NR
López-Bastida et al.
2008 [45]
Sample number: 84
Age range: 3–67 y (number
of children is not
specified)
Country: Spain
Degenerative cerebellar ataxia Cohort study NR NR
Martin et al. 2008 [43] Hypothetical children
Age:  5 y
Country: UK
Acute rotavirus gastroenteritis Valuation of
health states
Standartised proxy-
assessment by
paediatricians and
general
practitioners.
NR
Shaligram et al. 2007
[46]
Sample number: 39
Age range: 8–16 y
Country: India
Thalassemia Cohort study Self-assessment and
proxy-assessment
by carers
Concordance between self and proxy ratings: kappa 
0.394–0.845 (different domains)
(continued on next page)
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Table 2 (continued)
Reference Sample characteristics Health condition Type of study Mode of assessment Reliability and validity
Sach and Barton 2007
[39]
Sample number: 222
Mean age: 9.26 y
Country: UK
Cochlear implants Cohort study Proxy-assessment by
parents
Children with lower auditory perception had lower
estimated EQ-5D scores (P  0.05). EQ-5D was unable to
discriminate between children in the top three levels of
‘categories of auditory perception’. 16 of 222 had
missing data.
The majority of parents did not see HRQOL and QOL as
equivalent—mean difference between the two
constructs was 0.21.
van Baar et al. 2006 [10] Sample number: 145
Age range: 5–15 y
Country: Netherlands
Burns Cohort study Self-assessment for
10–15 y
proxy-assessment for
 9 y
BQQ scales ‘pain, ‘itch’ and ‘emotional health’ had high
correlation with equivalent EQ-5D domains. ‘Physical
Function and sports’ and ‘transfers and mobility’ were
related to EQ-5D ‘mobility’, ‘self care’ and ‘usual
activities’.
Concurrent validity compared to BOQ r  0.53 to
0.43 (across above domains).
Epps et al. 2005 [7] Sample number: 74
Age range: 4–19 y
Country: UK
Arthritis Randomised
controlled
trial
Proxy-assessment by
parents
NR
Oostenbrink et al. 2002
[36]
Paediatricians number: 28
Country: Netherlands
Permanent sequelae after
meningitis
Valuation of
health states
Standardised proxy-
assessment by
paediatricians
HUI-3A quality weights were significantly lower than EQ-
5D quality weights, except for ‘paresis of the leg’ and
‘severe mental retardation with tetraplegia.
Ekert et al. 2001 [44] Sample number: 6
Age range: 11–16 y
Country: Australia
Haemophilia Cohort study NR NR
Note: Interpretation of correlation coefficients: 0.1–29 low; 0.3–0.49 moderate;  0.5 high [61-2]. Interclass correlation coefficients (ICC)  0.7 are considered acceptable [61-2]. Effect size: 0.5–0.89
moderate,  0.8 large [22]; Cohen’s kappa  0.2 poor agreement, 0.21–0.40 fair agreement; 0.41–0.60 moderate agreement; 0.61–0.80 substantial agreement;  0.81 perfect agreement [61-2].
BOQ, the American Burn Association/Shriners Hospital for Children Burn Outcomes Questionnaire; CFQ, Cystic Fibrosis Questionnaire; CHIP-CE, Child Health and Illness Profile - Child Edition;
CHQ-PF50 Child Health Questionnaire-Parent Form; KIDSCREEN, a health-related quality of life instrument for children and adolescents; NR, not reported; SF-36, the Short Form-36 health survey
questionnaire; TACQOL, TNO-AZL (Netherlands Organisation for Applied Scientific Research Academic Medical Centre) Children’s Quality Of Life Questionnaire.
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Table 3 – Summary of the quality assessment of the EQ-5D versions.
Psychometric properties EQ-5D version
EQ-5D-Y Adult EQ-5D-3L Child Dutch EQ-5DC Not reported
Content validity
Are all important aspects of the
construct covered?
Internal consistency
The extent to which items in a
subscale are inter correlated thus
measuring the same construct
Criterion validity
Do scores agree with gold standard
measures?
Criterion validity: EQ-5D (index score)
compared to clinicians’ score r 
0.33;
Construct validity
Reflects the degree to which one
measure is similar (convergent
validity) or different (discriminant
validity) from another measure
Convergent validity compared to
KIDSCREEN: r  0.52–0.55
(different domains);
Convergent validity compared to
Cantril-ladder: r  0.37–0.1
(different domains);
Convergent validity compared to
CFQ: r  0.625 to 0.279
(different domains)
Convergent validity: EQ-5D (index score)
compared to CHQ-PF50 (different
domains): r  0.30–0.64; EQ-5D (index
score) compared to CHIP-CE (different
domains): r  0.24–0.51. Convergent
validity: EQ-5D (index score)
compared to SF-36 (different
domains) r  0.29–0.71;
Convergent validity compared to TACQOL:
r  0.54 to 0.15 for different
domains
Convergent validity compared to TACQOL
r  0.712 to 0.227 for different
domains.
Construct validity: mean correlation
between contextually similar domains
with TACQOL 0.55
Concurrent validity compared to
BOQ r  0.53–0.43 (different
domains).
HUI-3A quality weights were
significantly lower than EQ-5D
quality weights, except for
‘paresis of the leg’ and ‘severe
mental retardation with
tetraplegia.
Reliability
Reflects the temporal stability of an
instrument, such as test–retest
correlation.
Test–retest reliability:
69.8%–99.7%;
Test-retest reliability: ICC  0.25–1.00
Sensitivity
Ability of instrument to detect
changes in health status.
Ceiling effect: up to 99% Responsiveness: effect size  1.33 Ceiling effect: 50%
Concordance
Agreement/disagreement between
assessments provided by different
responders
ICC for VAS 0.82–0.83
Kappa coefficients up to 0.67
Concordance: child/parent
ICC  0.39–0.87; child/nurse
ICC  0.40–0.87
Concordance: kappa 
0.394–0.845 (different
domains)
Feasibility
Completion rates of an instrument.
Range 91%–100% (4 studies) 92%–99% (2 studies) 100% 87%
Note: Interpretation of correlation coefficients (ICCs): 0.1–29 low, 0.3–0.49 moderate, 0.5 high [56]. ICC 0.7 are considered acceptable [61-2]. Effect size: 0.5–0.89 moderate, 0.8 large [22]; Cohen’s
kappa  0.2 poor agreement, 0.21–0.40 fair agreement; 0.41–0.60 moderate agreement; 0.61–0.80 substantial agreement;  0.81 perfect agreement [61-2].
BOQ, the American Burn Association/Shriners Hospital for Children Burn Outcomes Questionnaire; CFQ, Cystic Fibrosis Questionnaire; CHIP-CE, Child Health and Illness Profile - Child Edition;
CHQ-PF50, Child Health Questionnaire-Parent Form; KIDSCREEN, a health-related quality of life instrument for children and adolescents; NR, not reported; SF-36, the Short Form-36 health survey
questionnaire; TACQOL, TNO-AZL (Netherlands Organisation for Applied Scientific Research Academic Medical Centre) Children’s Quality Of Life Questionnaire.
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1126 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 1 7 – 1 1 2 9adult version [21]. Both the child and adult versions of the EQ-5D
emonstrated problems with sensitivity due to high ceiling effect.
roblems were found with the ability of EQ-5D to distinguish be-
ween children with different health conditions. Lack of agree-
ent between self-assessments and proxy assessments was
hown for some EQ-5D domains.
Five studies investigated some but not all psychometric prop-
erties of child-friendly version EQ-5D-Y (Table 3). This version was
validated in the general population (n  2809) aged 8 to 18 years
from five countries: Germany, Italy, South Africa, Spain, and Swe-
den [20]. Feasibility of EQ-5D-Y varied from 91% to 100% for differ-
ent domains (Table 2). The highest number of missing scores
(2.3%) was reported for domain Mobility in South African children.
No missing items were found for all domains in Spanish and Ital-
ian population groups [20]. Several studies compared feasibility of
EQ-5D-Y and the EQ-5D adult version [21,35]. In the South African
study the feasibility of the adult version varied from 92% to 93%,
compared to 98% for EQ-5D-Y [35].
Test–retest reliability of EQ-5D-Y (7 to 10 days) ranged from
69.8% to 99.7%. The instrument had good convergent validity
when compared with children-specific HR-QoL instruments, such
as KIDSCREEN and Life satisfaction ladder, with the highest corre-
lation (r0.52) for the emotional domain Feeling Worried, Sad or
Unhappy. The study reported a high ceiling effect (e.g., 99% for the
domain Looking After Myself) [20]. A study by Burström et al. [37]
demonstrated discriminative validity of EQ-5D-Y for children with
different health conditions including asthma, rhinitis, severe ill-
ness and/or disability. Convergent validity was shown for EQ-5D-Y
when compared with cystic fibrosis questionnaire scales, with the
highest correlation (0.625) being for the dimension Mobility [28].
Two studies examined feasibility, test–retest reliability, and
onstruct validity of the Dutch EQ-5D child version [24,26]. Stolk et
l. [24] demonstrated high feasibility (one missing item) of the
Dutch EQ-5D child version for children with imperforate anus. The
instrument had good convergent validity (the mean correlation
score  0.55) compared to TACQOL [24]. Test–retest reliability (2
weeks) was tested using children with different health conditions,
including asthma, rheumatic disorders, diabetes, and speech/lan-
guage and/or hearing disorders [26]. Expressed as interclass corre-
lation coefficients, test-retest reliability of the Dutch EQ-5D child
version varied for different domains from -0.25 to 1.0 [27]. Prob-
lems were found with discriminant power, because the EQ-5D (in
contrast to TACQOL) was not able to distinguish between children
with different disorders. Therefore, additional disease-specific
HR-QoL instruments have been recommended for use together
with Dutch EQ-5D child version [26].
Two studies used EQ-5DC in children with schistosomiasis
and childhood injury [11,25]. The performance of this version,
however, was not properly examined. EQ-5DC had the lowest
feasibility amongst all the tested versions, because 13% of items
were found to be missing in the study of children with injuries [25].
Feasibility, construct validity, discriminant validity, and crite-
rion validity of the adult EQ-5D version was investigated in chil-
dren with orthopaedic problems and attention-deficit hyperactiv-
ity disorder [6,8]. Feasibility of the adult version of EQ-5D, tested in
patients with orthopedic problems aged 10 to 18 years, was greater
than 98% for all health domains [6]. Construct validity of the adult
version of EQ-5D with respect to correspondent SF-36 domains
varied from 0.29 to 0.71, with the highest coefficient being for the
pain domain. Criterion validity, estimated as the correlation be-
tween EQ-5D total score and clinical severity score, was 0.33 [6].
The adult EQ-5D version was not able to discriminate between
groups of children with different orthopaedic problems, such as
cerebral palsy and idiopathic scoliosis. The adult EQ-5D version,
like the EQ-5D-Y [20], was characterized by a high ceiling effect in
children (50%) [6]. Due to problems relating to ceiling effect and gdiscriminant validity, the adult version of EQ-5D was not recom-
mended for use in this population group [6].
Concordance between child and proxy-reported EQ-5D scores
was reported in studies of children with thalassemia [46] and
Hodgkin’s disease [33]. Correlation between child and parent as-
sessment in the thalassemia study varied for different domains
from 0.394 to 0.845 [46]. It was higher for observable domains such
as Mobility, Self-care, and Usual Activities, and lower for nonob-
servable domains such as Pain/discomfort [46]. In children with
Hodgkin’s disease the agreement between child and parent re-
ports was weaker than between child and nurse reports [33].
Discussion
EQ-5D reliability and validity in children
Overall, we found 29 studies that included four versions of the
EQ-5D, and 12 studies that did not report the specific version
used. All EQ-5D versions had large gaps of missing information
regarding psychometric properties. EQ-5D has been used in a
wide variety of study types, populations, and condition groups.
With respect to children, methodological concerns include ver-
sion appropriateness with different age groups, relevance of
domains, and examples used within domains specific to chil-
dren’s HR-QoL, and interpreting observed differences between
self and proxy reports.
It is generally accepted that HR-QoL is subjective because it
reflects an individual’s perceptions of health status [12,8]. There-
fore, HR-QoL should be assessed, whenever possible, from a pa-
tient’s perspective. There are a number of important aspects of
child’s HR-QoL that have been discussed in detail by Eiser et al. [12]
nd Matza et al. [8]. There are developmental differences in a
hild’s ability to understand the concept of health, disease, and
he influence of those on quality of life. The effects of disease and
reatment may be different in children and adults. As a result,
hildren do not necessarily share similar views as adults about the
ffects of illness on their lives. In addition, children differ in their
ognitive abilities to understand and complete HR-QoL question-
aires. Children’s HR-QoL instruments require age-appropriate
esign, which takes into account length, language, scaling, and
ormatting [8].
The child versions of EQ-5D (EQ-5D-Y and the Dutch EQ-5D
hild version) use age-appropriate language. For example, the
utch EQ-5D child questionnaire defines usual activities as play-
ng, helping with household, and going to school. EQ-5D-Y speci-
es the domain Usual Activities as going to school, hobbies, sports,
nd playing instead of work, study, housework, family or leisure
ctivities from the adult version. EQ-5D-Y uses “worried, sad, or
nhappy” instead of “anxious and depressed” from the adult ques-
ionnaire. Linguistic adaptation may explain higher feasibility of
Q-5D-Y compared to the adult EQ-5D version for children in the
eneral population [21,35].
Although EQ-5D-Y uses age-appropriate language, it does not
over many aspects of children’s HR-QoL, such as cognitive skills
nd family relationships, which are included in other generic in-
truments specifically designed for children (e.g., TACQOL and Pe-
iatric Quality of Life Inventory). This could be the reason for the
igh ceiling effect reported for both EQ-5D-Y [20] and adult EQ-5D
uestionnaires [6]. The ceiling effect for EQ-5D was also found in
ther population groups, such as people with dementia [47]; how-
ver, it was lower (43.4%–56.6%) than in children (50%–99%). Al-
hough we might not expect EQ-5D to distinguish between differ-
nt clinical diagnoses as it was designed primarily around generic
evels of physical functioning, the review showed that EQ-5D was
ble to distinguish between certain health conditions, such as
sthma, rheumatic disorders, and diabetes [26], but not between
roups of children with potentially similar conditions in terms of
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1127V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 1 7 – 1 1 2 9functioning such as orthopedic problems, cerebral palsy, and id-
iopathic scoliosis [6].
Reporting children’s HR-QoL
Sixteen studies used EQ-5D for child self-assessment and only five
studies were based solely on proxy assessment by parent, care-
giver, or health professional (Table 2). It is recognized that self-
report is the ideal strategy for HR-QoL assessment in children be-
cause it is consistent with the definition of HR-QoL. There are
many cases when children are not able to provide reliable and
valid data. For very young or severely disabled children proxy as-
sessment is the only way to obtain HR-QoL information. Studies
included in this review demonstrated differences, as might be ex-
pected, between EQ-5D ratings provided by children and proxies.
The level of agreement or difference between self-rerport and
proxy report varied for different EQ-5D domains [46]. The correla-
tion between child and proxy report was higher for observable
domains such as Mobility, Self-Care, and Usual Activities, and
lower for nonobservable domains such as Pain/Discomfort [46]. In
the study of children with Hodgkin’s disease the correlation be-
tween child and parent report was weaker than between child and
nurse report [33].
It is generally accepted that children can report their HR-QoL
starting from an age between 4 and 6 years [8]. An analysis of a
sample of 8591 children across different age subgroups indicated
that children as young as age 5 years can provide valid statements
with an age-appropriate instrument [48]. Assessment of less ob-
jective domains such as emotional effects of illness (e.g., anxiety
and depression) is appropriate for older children only [49]. Find-
ings indicate that EQ-5D-Y can be used for self-assessment in chil-
dren starting from age 9 years, whereas the adult EQ-5D version
was used from age 10 years, and the Dutch EQ-5D children version
was administered in children aged 12 years and older (Table 2).
EQ-5D and children’s QALYs
The most valuable characteristic of EQ-5D with respect to eco-
nomic evaluation is its ability to generate a universal measure of
health outcome, QALYs. In the absence of EQ-5D value sets for
children, adult tariffs have been used in economic evaluation
studies. When national tariffs were not available, value sets from
other countries were applied. There are concerns about the trans-
ferability of health state valuation from one country to another.
Knies et al. [19] found perceived differences between national
Q-5D value sets and preferences for the domains. In their study,
he utilities of two hypothetical health states showed that value
ets differed substantially and could be explained by methodo-
ogic differences in valuation studies and cultural differences may
eflect cultural dissimilarities between countries. Knies et al. [19]
ecommend that utilities should not be transferred across coun-
ries until further research is undertaken and a standardized ap-
roach to valuation studies is agreed.
The cost-effectiveness of health interventions can be ex-
ressed as cost per QALY, and this ratio is often used in making
ecisions about the allocation of resources. To generate QALYs,
Q-5D health states are converted into a single summary index
sing utility (preference) weights, attached to each health state.
hese utility weights can be derived from a representative sample
f the general population using direct heath state valuation meth-
ds, such as standard gamble, time trade-off, and rating scales
e.g., VAS). Due to differences in cultural and socio-economic
ackground, EQ-5D value sets (tariffs) differ between countries. Up
o date EQ-5D value sets have been derived for 15 countries [19]. A
et of weights for use with European populations (8709 people) has
een generated from national studies. The UK tariffs were gener-
ted from 3395 people using both time trade-off and EQ-5D-VAS
ethods [2].Despite the major advantage of EQ-5D as a source of QALYs, the
majority of studies captured by this review used EQ-5D to generate
health profiles. We can hypothesize that one reason for the limited
use of EQ-5D in economic evaluations of health care interventions
for children is that the EQ-5D value sets have been derived for the
adult population and no utility weights are currently available for
children. If there should be a separate set of children’s tariffs is a
philosophical question about whose values should count when
adults are making decisions about resource allocation in chil-
dren’s services. Deriving utilities for children could also be practi-
cally challenging because young children may not have the cogni-
tive ability to complete the valuation task. This means that proxy
valuation of children’s health states by parents or health care pro-
fessionals could have to be used, thereby taking us back to essen-
tially using adult values in making decisions about resource allo-
cation in children’s services. There is debate about the most
appropriate source of information for the valuation of children’s
health states, especially for children who are not able to provide
relevant information (e.g., very young or cognitively disabled). Par-
ents are often perceived as more appropriate proxy respondents
because their reports better agree with children’s reports than
assessments made by clinicians [50]. However, some researchers
believe that clinicians provide a more objective assessment of
children’s HR-QoL [13]. The only HR-QoL instrument currently
available with specific children’s health utilities, HUI mark 2, is
based on interviews with parents of school-aged children (essen-
tially proxy values), conducted in Canada [51].
Despite the large number of generic HR-QoL instruments, only
a few of them are preference-based and hence suitable for the
calculation of QALYs. In addition to EQ-5D, these include HUI mark
2 and 3 [52], Quality of Well-Being scale [53], and SF-6D (a trun-
ated version of SF-36) [54]. Population-based values for health
tates have recently been established for SF-6D using the standard
amble approach [54]. All these instruments, except HUI mark 2
ave utility weights assigned for adults, not children. A review by
riebsch et al. [13] focused on cost-utility studies, which use ge-
eric HR-QoL instruments to compare child health interventions
n terms of their costs and benefits. The authors critically ap-
raised 54 studies with respect to methods used to calculate
ALYs. Twelve of these studies used HUI, five of the studies used
Q-5D, and two of the studies used the Quality of Well-Being scale.
ther studies used direct valuation techniques (standard gamble
nd time trade off), referrals to previously published studies or
on-identified sources [13]. A review by Tarride et al. [55], con-
ucted 5 years later, found 33 studies that used HUI and 26 studies
hat used EQ-5D to derive utilities for children. Because HUI mark
remains the most frequently used preference-based HR-Qol in-
trument, specifically designed for children, the NICE recom-
ends HUI mark 2 for the assessment of children’s health tech-
ologies [4].
Strengths and limitations
To our knowledge, no previous review has systematically reported
the psychometric properties, use, strengths, and limitations of the
EQ-5D in studies with children. Review findings represent the cur-
rent state of the art and science of EQ-5D use in children’s studies,
and identify gaps in knowledge that require addressing.
Although we searched a wide number of databases, we ac-
knowledge that we may have missed some studies. As a safety net,
we conducted an additional Internet search and searched the Eu-
roQol database of studies using the EQ-5D, to mitigate the poten-
tial for missing relevant studies.
Implications for practice and research
Assessment of HR-QoL in children remains a significant challenge
in general and for economic analysis purposes, specifically in
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1128 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 1 7 – 1 1 2 9terms of describing and valuing health states, and the appropriate
mode of administration and use of proxies where appropriate.
When compared directly, children and young people found the
EQ-5D-Y easier to complete than the adult EQ-5D, but more re-
search is warranted to understand better why more problems
were reported on the child version compared with the adult ver-
sion. At the current stage of EQ-5D adaptation for use in children’s
populations, all practical recommendations based on the calcula-
tion of children’s QALYs, should be taken with extreme caution.
Inclusion of EQ-5D in studies with children, allowing for cave-
ats set out in the discussion does enable comparison of cost effec-
tiveness of children’s interventions and services in comparison to
other uses of adult and children’s health and social care resources.
While appreciating that poor approximation is better than no ap-
proximation at all, researchers and service commissioners should
be very careful in interpreting cost-effectiveness models of chil-
dren’s health-care interventions and consider the appropriate-
ness of data incorporated into these models. To address the meth-
odologic and philosophical issues identified, we recommend that:
1. At the design stage of a study, the choice of outcome measures
is evidence based and that the choice of EQ-5D version is clearly
identified and the rationale for choice made explicit;
. EQ-5D is used alongside other age-appropriate and disease-spe-
cific measures to allow methodological analysis of the perfor-
mance of EQ-5D in that specific context (e.g., age group and
disease group);
. Researchers should consider the opportunity to undertake fur-
ther nested methodological work within studies to refine the
use of HR-QoL measures in studies of children’s interventions;
. There are important philosophical questions alongside future
studies around the extent to which adult tariffs reflect the
views, particularly of teenagers, about health state values. The
implications of developing and using adult, or future specific
children’s, tariffs in resource allocation decisions for children’s
services, particularly children with life-limiting illnesses, war-
rants further investigation. Mixed-methods combining stan-
dard preference elicitation as well as qualitative research will
be needed to address these issues;
. The version(s) of EQ-5D need to be reported in the write up of
the study; and
. Psychometric properties of EQ-5D versions, and mode of ad-
ministration, version, and if self-report or by proxy, need to be
reported in studies in addition to other outcomes of interest.
Although EQ-5D is widely accepted and promoted by bodies
like NICE as a standard tool in economic evaluation, research con-
tinues into alternative approaches to describing, measuring, and
valuing HR-QoL. With respect to children, work on developing new
preference-based HR-QoL instruments specifically designed for
children (e.g., The Child Health Utility 9D) is currently underway
[56,57]. More generally in health economics there are ongoing
efforts that attempt to broaden the concept of HR-QoL beyond
primarily physical functioning (as in EQ-5D), based on capability
theory.
An alternative approach to obtain utility weights for calculat-
ing QALYs is based on measuring capabilities rather than prefer-
ences. The capability approach [58] advocates the evaluation of
rogrammes on the basis of the ability of a person to function in a
articular way, whether or not he or she chooses to do so. The
ndex of capability is a new quality of life measure that has been
sed in studies with older adults [59]. The version for adults, is
ow under development [60]. The capabilities approach may offer
otential means of overcoming existing concerns about the valid-
ty of EQ-5D in children.
Our key message to researchers faced with the challenge of
easuring and valuing HR-QoL in children, particularly for the
urpose of economic evaluation, is to explore the current optionsavailable (i.e., EQ-5D in its various versions, HUI mark 2 and 3)
alongside children’s quality of life and disease-specific measures;
and to explore the most appropriate mode of administration, and
where possible to obtain self-report from children and to obtain
proxy measures from parents, caregivers, or health-care profes-
sionals, particularly for younger children and those with cognitive
impairment. Methodologic studies offer an opportunity to report
cost per QALY figures for using children’s self-report for compar-
ison with parental proxy. It may be that a cost consequence anal-
ysis approach is the most appropriate way to display the full range
of costs and outcomes in the evaluation of children’s services,
thereby allowing the research community to be explicit about the
process by which health benefits to children are measured and
valued.
Conclusions
There is limited experience of using the EQ-5D in children’s stud-
ies. Existing literature lacks detail on the specific use of EQ-5D and
its potential influence on findings. Version use and psychometric
properties are inadequately reported. There are large gaps in cur-
rent knowledge of psychometric properties across all versions
when used with children. For reasons of comparability with re-
source use across adult and children’s services there are argu-
ments for continued use of EQ-5D in studies with children, but that
it is necessary to use EQ-5D alongside children-specific quality of
life measures and disease-specific measures. Researchers are en-
couraged to undertake methodological and philosophical analyses
to better understand and improve evidence as to how adults who
make decisions about resource allocation can best take account of
children in decision making.
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